michigan glp-1 gi obstruction class action digestive blockage The microbial tryptophan metabolite indole acts on the gastrointestinal GLP-1 and GIP in Type
Description
The semaglutide NASH trial (NEJM 2021) showed NASH resolution but uncertain effects on fibrosis
Activating GIP receptors appears to promote bone formation and inhibit bone resorption, at least in preclinical studies
(1996a) Heterologous desensitization of the glucagon-like peptide-1 receptor by phorbol esters requires phosphorylation of the cytoplasmic tail at four different sites
Comprehensive pharmacokinetic (PK) and anti-drug antibody (ADA) assessments are essential for optimizing dosing regimens, ensuring therapeutic efficacy, and maintaining safety
